AppFolio posts loss in fourth quarter
AppFolio, a Goleta-based property management software company, failed to meet analysts’ expectations with a net loss in the fourth quarter of 2020. Analysts tracked by Zacks Equity Research had predicted earnings per share of 13 cents, similar to AppFolio’s performance in the fourth quarter of 2019. Instead, the company suffered a net loss of $513,000 Read More →
MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Inogen announces net loss, predicts better 2021
Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
AeroVironment makes $30M AI acquisition
AeroVironment, a drone company based in Simi Valley, announced Feb. 24 that it has acquired the Intelligent Systems Group from Progeny Systems Corp. for $30 million or more in cash. The Intelligent Systems Group develops intelligence-enabled computer vision, machine learning and perceptive autonomy technologies and provides those services to United States government customers, AeroVironment said. Read More →
LTC Properties reports income jump in fourth quarter
LTC Properties saw steady returns and a higher net income than a year ago when it reported its finances for the fourth quarter of 2020. The Westlake Village-based real estate investment trust, which focuses on senior housing and health care properties, reported net income of $17.5 million, or 45 cents per diluted share, for 2020’s Read More →
Arcutis shares flat on earnings report
Arcutis Biotherapeutics saw a steep rise in operating expenses resulting in a 183% increase in net loss compared to the previous year when the company revealed its fourth quarter and full-year financial results on Feb. 16. However, the Westlake Village biotech company is still in high spirits, as the company is in a “strong financial Read More →